2nd Quarter - Report

BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.) for BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)

Period 2nd Quarter 2026 Filed Jul 20, 2026 Signed by Laura Whitton

Official filing
Firm
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Client
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Income
—
Expenses
$220,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

H.R. 8646, Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2027; H.R. 9620, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027; Issues pertaining to NIH & FDA funding.

LobbyistCovered position, as disclosed
CHRISTINA INGRAM —
DON LYSTER —
PEDRO MONTENEGRO —
LAURA WHITTON —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 9620 (119th), H.R. 8646 (119th)

Health Issues HCR

S. 4189 - the INSULIN Act; S. 4612/H.R. 9000 - the SCREEN For T1D Act; S. 4612, the SCREEN for T1D Act; H.R. 5467 - the Patient Access to Autoimmune Treatments Act; S. 8270/H.R. 8018 - the ISLET Act; Issues pertaining to cell and gene therapies; Issues pertaining to C-peptide; Issues pertaining to NIH research; Issues pertaining to Special Diabetes Program.

LobbyistCovered position, as disclosed
CHRISTINA INGRAM —
DON LYSTER —
PEDRO MONTENEGRO —
LAURA WHITTON —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5467 (119th), S. 4189 (119th), H.R. 9000 (119th), S. 4612 (119th), S. 8270 (119th), H.R. 8018 (119th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.